Rosai-Dorfman Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Mirdametinib in Histiocytic Disorders
Conditions: Langerhans Cell Histiocytosis (LCH); Juvenile Xanthogranuloma (JXG); Rosai-Dorfman Disease (RDD); Histiocytic Disorders Interventions: Drug: Mirdametinib Sponsors: Children ' s Hospital Medical Center, Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Central China Rosai-Dorfman Disease Registry
Conditions: Rosai-Dorfman Disease; Langerhans Cell Histiocytosis Intervention: Drug: Mycophenolate mofetil combined with oral prednisone Sponsor: Tongji Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2022 Category: Research Source Type: clinical trials
Lenalidomide and Dexamethasone for Rosai-Dorfman Disease
Condition: Rosai-Dorfman Disease Intervention: Drug: lenalidomide and dexamethasone Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2021 Category: Research Source Type: clinical trials
